ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

IRON vs OGN // EV/EBITDA & P/E VALUATION

Disc Medicine Inc. (NASDAQ) VS. Organon & Co. (NYSE) • 15-METRIC TALLY: IRON 2 — OGN 7
■ METRIC PARITY
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (IRON VS. OGN) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC IRON OGN SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin — 53.30% — TIE /gross-margins <GO>
Return on Invested Capital (ROIC) -27.50% 24.90% -52.40 OGN /roic <GO>
EV/EBITDA & P/E Valuation ACTIVE — — — TIE /valuation <GO>
Free Cash Flow Yield -4.93% 14.83% -19.76 OGN /fcf-yield <GO>
Operating Margin -22.90% — — TIE /operating-margins <GO>
Net Profit Margin -20.60% 3.00% -23.60 OGN /net-margins <GO>
Revenue Growth (YoY) 16.50% -2.90% +19.40 IRON /revenue-growth <GO>
Dividend Yield & FCF Payout Safety 0.00% 2.43% -2.43 OGN /dividend-safety <GO>
Altman Z-Score & Debt/Equity 26.00 — — TIE /balance-sheet <GO>
Piotroski F-Score Quality 5/9 6/9 -1.00 OGN /piotroski-score <GO>
Options Implied Move & Put/Call Skew — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 67.0 67.8 -0.76 OGN /rsi-technicals <GO>
10Y Yield & FRED Macro Beta 0.90 — — TIE /macro-sensitivity <GO>
Forward P/E Multiple 20.0x 18.0x +2.00 OGN /forward-pe <GO>
Enterprise Scale & Market Cap $3.68B $3.63B $50.9M IRON /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR IRON REV OGN REV IRON GROSS % OGN GROSS % IRON FCF OGN FCF
FY 2025 $0 $6.22B — 53.3% -$181.3M $538.0M
FY 2024 $0 $6.40B — 58.0% -$94.4M $764.0M
FY 2023 $0 $6.26B — — -$73.5M $799.0M
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
IRON // BETA 0.90
OGN // BETA —